Factors associated with treatment for latent tuberculosis in persons living with HIV/AIDS

Fatores associados ao tratamento da tuberculose latente em pessoas vivendo com HIV/AIDS;
Factores asociados al tratamiento de la tuberculosis latente en personas viviendo con VIH/SIDA

dc.creatorAquino, Daniela Silva de
dc.creatorMoura, Líbia Cristina Rocha Vilela
dc.creatorMaruza, Magda
dc.creatorSilva, Adriana Paula da
dc.creatorXimenes, Ricardo Arraes de Alencar
dc.creatorLacerda, Heloísa Ramos
dc.creatorMiranda Filho, Demócrito de Barros
dc.creatorAlbuquerque, Maria de Fátima Pessoa Militão de
dc.date2017-09-12T15:03:34Z
dc.date2017-09-12T15:03:34Z
dc.date2015
dc.date.accessioned2023-09-26T23:05:59Z
dc.date.available2023-09-26T23:05:59Z
dc.identifierAQUINO, D. S. DE et al. Factors associated with treatment for latent tuberculosis in persons living with HIV/AIDS. Cadernos De Saude Publica, v. 31, n. 12, p. 2505–2513, dez. 2015.
dc.identifier1678-4464
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/20964
dc.identifier10.1590/0102-311X00154614
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8886828
dc.descriptionThe aim was to identify factors associated with non-initiation of prophylactic treatment of latent tuberculosis infection (LTBi) in persons living with HIV/AIDS (PLWA), based on a prospective cohort study of PLWA ≥ 18 years of age in two referral services for HIV/AIDS. Of the 232 patients eligible for treatment of LTBi, 69.8% initiated treatment. Following multivariate logistic regression analysis, only treatment in one of the two referral services was associated with non-initiation of treatment for LTBi (p < 0.001). TB incidence in the cohort was 0.6/100 person-years. TB incidence in patients that initiated treatment of LTBi was 0.4/100 person-years, compared to 1.2/100 person-years in those that did not initiate treatment, but the difference was not statistically significant. The study's most interesting finding was that the main factor associated with the likelihood of treatment for LTBi was the health service where the patient was treated.
dc.formatapplication/pdf
dc.languagepor
dc.rightsopen access
dc.subjectInfecções por HIV
dc.subjectAntituberculosos
dc.subjectIsoniazida
dc.subjectTuberculose Latente
dc.subjectAdult
dc.subjectAntitubercular Agents
dc.subjectAntitubercular Agents
dc.subjecttherapeutic use
dc.subjectIsoniazid
dc.subjectLatent Tuberculosis
dc.subjectcomplications
dc.subjectdiagnosis
dc.subjectdrug therapy
dc.subjectepidemiology
dc.subjectMale
dc.subjectRisk factors
dc.subjectProspective Studies
dc.subjectHumans
dc.subjectAdultos
dc.subjectInfecções por HIV
dc.subjectAntituberculosos
dc.subjectFeminino
dc.subjectIsoniazida
dc.subjectTuberculose Latente
dc.subjectMasculino
dc.subjectEstudos prospectivos
dc.subjectFatores de risco
dc.subjectHumanos
dc.titleFactors associated with treatment for latent tuberculosis in persons living with HIV/AIDS
dc.titleFatores associados ao tratamento da tuberculose latente em pessoas vivendo com HIV/AIDS
dc.titleFactores asociados al tratamiento de la tuberculosis latente en personas viviendo con VIH/SIDA
dc.typeArticle


Este ítem pertenece a la siguiente institución